Page last updated: 2024-08-25

methotrexate and Aortic Arteritis, Giant Cell

methotrexate has been researched along with Aortic Arteritis, Giant Cell in 109 studies

Research

Studies (109)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (0.92)	18.7374
1990's	13 (11.93)	18.2507
2000's	32 (29.36)	29.6817
2010's	33 (30.28)	24.3611
2020's	30 (27.52)	2.80

Authors

Authors	Studies
Ercole, L; González-Gay, MA; Ortego-Centeno, N	1
Becker, J; Bley, TA; Hellmich, B; Kraemer, M; Minnerup, J; Steinbrecher, A	1
Camellino, D; Caporali, R; Carrara, G; Cimmino, MA; Crotti, C; De Vita, S; El Aoufy, K; Emmi, G; Monti, S; Morbelli, S; Muratore, F; Padoan, R; Quartuccio, L; Rozza, D; Salvarani, C; Sciascia, S; Tonolo, S; Ughi, N; Zanetti, A	1
Bolhuis, TE; den Broeder, AA; den Broeder, N; Marsman, DE; van der Maas, A	1
Aussedat, M; Cucherat, M; Durieu, I; Grenet, G; Gueyffier, F; Lega, JC; Lobbes, H; Mainbourg, S; Samson, M; Tabary, A	1
Darrow, HJ; Raleigh, MF; Stoddard, J	1
Horák, P; Hraboš, D; Skácelová, M; Skoumalová, A; Videman, J	1
Brugarolas, E; Estrada, P; LLop, D; Maymó-Paituvi, P; Narváez, J; Nolla, JM; Palacios-Olid, J; Vidal-Montal, P	1
Akahoshi, M; Boyadzhieva, Z; Buttgereit, F; Hermann, S; Muche, B; Palmowski, A; Terao, C; Wiebe, E	1
Man-Ger Sun, M; Pope, JE	1
Aouba, A; Boutemy, J; de Boysson, H; Deshayes, S; Dumont, A; Gallou, S; Lavergne, A; Maigné, G; Nguyen, A; Philip, R; Silva, NM	1
Bonnotte, B; Greigert, H; Samson, M	1
Hernández, C; Karsulovic, C; Mac-Namara, M; Sabugo, F; Wurmann, P; Zamorano, P	1
Villiger, PM	1
Águeda, AF; Buttgereit, F; Cid, M; Dejaco, C; Hellmich, B; Luqmani, RA; Mahr, A; Monti, S; Ponte, C; Salvarani, C; Schmidt, W	1
Allali, D; Blondon, M; Roux-Lombard, P; Spoerl, D	1
Black, R; Hill, C; Nguyen, L; Proudman, S; Ruediger, C	1
Hellmich, B; Horvath, L	1
Holle, JU; Moosig, F	1
Schmidt, WA	1
Mahmood, SB; Nasr, R; Nelson, E; Padniewski, J	1
Buttgereit, F; Dejaco, C; Matteson, EL	1
Águeda, AF; Hellmich, B; Luqmani, R; Monti, S	1
Buttgereit, F; Palmowski, A	1
Lee, YH; Song, GG	1
Hellmich, B	2
Boiardi, L; Casali, M; Cavallaro, A; Corte, G; Crescentini, F; Galli, E; Kuwert, T; Manger, B; Muratore, F; Rech, J; Roth, J; Salvarani, C; Schett, G; Schmidt, D; Schönau, V; Spaggiari, L; Tascilar, K; Uder, M; Versari, A	1
Matsushita, S; Taito, S; Yamamoto, N	1
Cacoub, P; Dechartres, A; Gérard, AL; Saadoun, D; Simon-Tillaux, N; Tubach, F; Yordanov, Y	1
Garvey, TD; Koster, MJ; Warrington, KJ	1
Deuter, C; Kötter, I; Stübiger, N	1
Aggarwal, I; Berry, GJ; Liao, YJ; Sab, UK; Uribe, JA; Weyand, CM; Witthayaweerasak, J	1
Boers, N; den Broeder, AA; Marsman, DE; van der Maas, A	1
Berti, A; Cornec, D; Matteson, EL; Medina Inojosa, JR; Murad, MH	1
Blanco, R; Calderon-Goercke, M; Castañeda, S; González-Gay, MA; Pina, T; Prieto-Peña, D	1
Crowson, CS; Koster, MJ; Labarca, C; Muratore, F; Warrington, KJ; Yeruva, K	1
Diamantopoulos, AP; Myklebust, G; Tengesdal, S	1
Calderon-Goercke, M; Castañeda, S; González-Gay, MÁ; Gualillo, O; Pina, T; Prieto-Peña, D	1
Brouwer, E; Sandovici, M; VAN DER Geest, KSM	1
Agueda, A; Brouwer, E; Buttgereit, F; Cassie, R; Cid, MC; Dasgupta, B; de Boysson, H; Dejaco, C; Hatemi, G; Hellmich, B; Hollinger, N; Luqmani, RA; Mahr, A; Mollan, SP; Monti, S; Mukhtyar, C; Ponte, C; Salvarani, C; Schmidt, W; Sivakumar, R; Tian, X; Tomasson, G; Turesson, C; Villiger, PM; Watts, R; Young, C	1
Bonnotte, B; Ghesquière, T; Greigert, H; Samson, M	1
Belhassen, M; Devauchelle-Pensec, V; Gandon, S; Hachulla, E; Idier, I; Mahr, A; Nolin, M; Paccalin, M	1
Abrantes, F; Bacchiega, AB; Okamoto, KY; Schau, B; Shinjo, SK; Souza, AW	1
Loke, YK; MacGregor, AJ; Watts, RA; Yates, M	1
Berti, A; Campochiaro, C; Cavalli, G; Dagna, L; Doglioni, C; Gerevini, S; Guglielmi, B; Sabbadini, MG	1
Hisada, R; Jodo, S	1
Magliano, M; Mankia, KS; Tucker, LJ	1
Cei, M; Dentali, F; Mumoli, N; Vitale, J	1
Barreto, P; Fior, A	1
Eiber, M; Einspieler, I; Thürmel, K	1
Buttgereit, F; Dasgupta, B; Dejaco, C; Matteson, EL	2
Alivernini, S; Berardi, G; Biscetti, F; Bosello, SL; Carbonella, A; Fedele, AL; Ferraccioli, G; Gremese, E; Petricca, L	1
Pastor-Asurza, C; Pimentel-Quiroz, VR; Sumire-Umeres, J; Ugarte-Gil, M	1
Bienvenu, B; de Boysson, H; Samson, M; Watelet, B	1
Muratore, F; Pipitone, N; Salvarani, C	1
Liozon, E; Ly, K	1
Corchero, C; Diaz-Lopez, C; Diaz-Torne, C; Narvaez, J; Nolla, JM; Pou, MA; Vidal, S	1
Biousse, V; Fraser, JA; Newman, NJ; Weyand, CM	1
Hall, JK	1
Märker-Hermann, E; Schmidt, WA	1
Agudo, M; Blanco, R; Gonzalez-Gay, MA; Llorca, J; Martinez-Dubois, C; Pompei, O	1
Balsalobre Aznar, J; Porta-Etessam, J	1
Alba, MA; Flores-Suárez, LF; Mena-Madrazo, JA; Reyes, E	1
Borchers, AT; Gershwin, ME	1
Besada, E; Nossent, JC	1
Ameloot, K; De Wever, W; Goffin, K; Palmers, PJ; Voigt, JU	1
Baca, S; Bork, D; Calabrese, LH; Choi, HK; Cid, MC; Cohen, P; Dickler, H; Easley, KA; Ferland, D; Fessler, BJ; Flynn, JA; Fortin, P; Gross, W; Guillevin, L; Hellmann, DB; Hernández-Rodríguez, J; Hoffman, DB; Hoffman, GS; Hunder, GG; Kalunian, K; Klashman, D; Kosmorsky, G; Locker, GA; Lopez-Soto, A; Ludivico, C; Luqmani, RA; Mandell, BF; McRorie, E; Merkel, PA; Nuki, G; Prayson, R; Puechal, X; Scheetz, RJ; Schned, E; Schousboe, J; Segal, AM; Sherrer, Y; Sneller, MC; Soubrier, M; Stone, JH; Swanson, H; Tuggle, C; Walsh, B; Wilke, WS	1
Ben-Ami, H; Fruchter, O; Gaitini, D; Gallimidi, Z; Goldsher, D; Schapira, D	1
Schnabel, A	1
Bañares, A; Fernandez-Gutierrez, B; Hernández-Garcia, C; Jover, JA; Morado, IC; Vargas, E	2
Kupersmith, M; Paget, S; Spiera, H; Spiera, RF	1
Caceres, LR; Lichtstein, DM	1
Seton, M	1
Sailler, L	1
Bañuls, SR; Ripoll, JM; Sanchis, AM; Zaragoza, JM	1
Heathcote, JG; Proulx, A; Rizkalla, K; Rodrigues, S; Tingey, DP	1
Boulman, N; Eder, L; Feld, J; Rimar, D; Rosner, I; Rozenbaum, M; Slobodin, G; Zisman, D	1
Machera, H; Skoura, C; Spanou, A; Zachariades, N	1
Randhawa, S; Van Stavern, GP	1
Fernández-Gutiérrez, B; Hernández-García, C; Jover, JA; Lavalley, MP; Mahr, AD; Merkel, PA; Spiera, RF	1
Yazici, Y	1
Cid, MC; Espígol-Frigolé, G; García-Martínez, A; Hernández-Rodríguez, J; Lozano, E	1
Käser, L; Kolyvanos Naumann, U; Nigg, C; Vetter, W	1
Danesh-Meyer, HV; Savino, PJ	1
Pipitone, N; Salvarani, C	1
Hoffman, GS; Wilke, WS	1
Bañares, A; Fernández-Gutiérrez, B; Hernández-García, C; Herrero, M; Jover, JA; Morado, C; Ramos, P; Soriano, C	1
Nesher, G; Sonnenblick, M	1
Bijlsma, JW; Dinant, HJ; van Albada-Kuipers, GA; van Booma-Frankfort, C; van der Veen, MJ	1
Hoffman, GS; Langford, CA; Sneller, MC	1
Bahlas, S; Davis, P; Ramos-Remus, C	1
Mantaka, P; Nüsslein, H; Schwarz-Eywill, M; Unger, L; Wittek, A	1
Giuliani, MJ; Lacomis, D; Oddis, CV; Wasko, MC	1
Roblot, P	1
Kupersmith, MJ; Langer, R; Mitnick, H; Paget, S; Richmond, M; Spiera, H; Spiera, R	1
Généreau, T	1
Gibbons, RB; Krebs, S	1
Bie, RB; Haugeberg, G; Paulsen, PQ	1
Alarcón, GS; Morgan, SL	1
Paget, S; Spiera, H; Spiera, RF	1
Hellmann, DB; Levine, SM	1
Barilla-LaBarca, ML; Brasington, RD; Lenschow, DJ	1
Airò, P; Antonioli, CM; Toniati, P; Vianelli, M	1
Hoffman, GS	1
Krall, PL; Mazanec, DJ; Wilke, WS	1

Reviews

52 review(s) available for methotrexate and Aortic Arteritis, Giant Cell

Article	Year
[Diagnostics and treatment of giant cell arteritis]. Der Nervenarzt, 2022, Volume: 93, Issue:8 Topics: Drug Therapy, Combination; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Middle Aged; Recurrence	2022
The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis. Reumatismo, 2022, Feb-07, Volume: 73, Issue:4 Topics: Giant Cell Arteritis; Humans; Italy; Methotrexate; Rheumatology; Takayasu Arteritis	2022
Indirect Comparison of Glucocorticoid-Sparing Agents for Remission Maintenance in Giant Cell Arteritis: A Network Meta-analysis. Mayo Clinic proceedings, 2022, Volume: 97, Issue:10 Topics: Adalimumab; Etanercept; Giant Cell Arteritis; Glucocorticoids; Humans; Infliximab; Methotrexate; Network Meta-Analysis; Randomized Controlled Trials as Topic	2022
Efficacy and safety of leflunomide in the management of large vessel vasculitis: A systematic review and metaanalysis of cohort studies. Seminars in arthritis and rheumatism, 2023, Volume: 59 Topics: Antirheumatic Agents; Cohort Studies; Giant Cell Arteritis; Glucocorticoids; Humans; Leflunomide; Methotrexate; Recurrence; Takayasu Arteritis	2023
Unmet need in the treatment of polymyalgia rheumatica and giant cell arteritis. Best practice & research. Clinical rheumatology, 2022, Volume: 36, Issue:4 Topics: Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Polymyalgia Rheumatica	2022
Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis. RMD open, 2019, Volume: 5, Issue:2 Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Biomarkers; Blindness; Drug Therapy, Combination; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Methotrexate; Observational Studies as Topic; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Recurrence; Risk Management; Systemic Vasculitis; Takayasu Arteritis	2019
[Treatment of giant cell arteritis: what is in the pipeline?] Zeitschrift fur Rheumatologie, 2020, Volume: 79, Issue:6 Topics: Antibodies, Monoclonal, Humanized; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Remission Induction; Treatment Outcome	2020
[Inflammatory Muscle Pain: Polymyalgia Rheumatica with or without Large Vessel Vasculitis]. Deutsche medizinische Wochenschrift (1946), 2020, Volume: 145, Issue:13 Topics: Aged; Antibodies, Monoclonal, Humanized; Blindness; Diagnosis, Differential; Fatigue; Female; Giant Cell Arteritis; Humans; Methotrexate; Polymyalgia Rheumatica; Prednisolone; Stroke; Ultrasonography; Vasculitis	2020
Polymyalgia rheumatica: An updated review. Cleveland Clinic journal of medicine, 2020, Aug-31, Volume: 87, Issue:9 Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Blood Sedimentation; Diagnosis, Differential; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Induction Chemotherapy; Male; Methotrexate; Middle Aged; Polymyalgia Rheumatica; Ultrasonography	2020
Polymyalgia Rheumatica and Giant Cell Arteritis. JAMA, 2020, Sep-08, Volume: 324, Issue:10 Topics: Antibodies, Monoclonal, Humanized; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography	2020
Treatment of Giant Cell Arteritis and Takayasu Arteritis-Current and Future. Current rheumatology reports, 2020, 10-12, Volume: 22, Issue:12 Topics: Antibodies, Monoclonal, Humanized; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Recurrence; Takayasu Arteritis	2020
Reducing the Toxicity of Long-Term Glucocorticoid Treatment in Large Vessel Vasculitis. Current rheumatology reports, 2020, 10-12, Volume: 22, Issue:12 Topics: Antibodies, Monoclonal, Humanized; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Takayasu Arteritis	2020
Methotrexate for treating polymyalgia rheumatica: A meta-analysis of randomized controlled trials. International journal of clinical pharmacology and therapeutics, 2021, Volume: 59, Issue:5 Topics: Antirheumatic Agents; Giant Cell Arteritis; Humans; Methotrexate; Polymyalgia Rheumatica; Randomized Controlled Trials as Topic; Treatment Outcome	2021
[Glucocorticoids in the treatment of giant cell arteritis : How much, how long and how to spare?] Zeitschrift fur Rheumatologie, 2021, Volume: 80, Issue:4 Topics: Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Osteoporosis; Recurrence	2021
Efficacy and safety of steroid-sparing treatments in giant cell arteritis according to the glucocorticoids tapering regimen: A systematic review and meta-analysis. European journal of internal medicine, 2021, Volume: 88 Topics: Drug Therapy, Combination; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Steroids	2021
My Treatment Approach to Giant Cell Arteritis. Mayo Clinic proceedings, 2021, Volume: 96, Issue:6 Topics: Antibodies, Monoclonal, Humanized; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Remission Induction	2021
[Ocular involvement in rheumatoid arthritis, connective tissue diseases and vasculitis]. Zeitschrift fur Rheumatologie, 2017, Volume: 76, Issue:8 Topics: Acute Disease; Adrenal Cortex Hormones; Arthritis, Rheumatoid; Aspirin; Collagen Diseases; Cross-Sectional Studies; Eye Diseases; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Keratoconjunctivitis Sicca; Lupus Erythematosus, Systemic; Methotrexate; Retinal Diseases; Scleritis; Uveitis, Anterior; Vascular Diseases	2017
Refractory Giant Cell Arteritis Complicated by Vision Loss From Optic Atrophy and Maculopathy Associated With Pachymeningitis. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2018, Volume: 38, Issue:1 Topics: Aged; Autoantibodies; Autoantigens; Blindness; Computed Tomography Angiography; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Meningitis; Methotrexate; Optic Atrophy; Prednisone; Retina; Retinal Diseases	2018
[Polymyalgia rheumatica: new developments and challenges]. Nederlands tijdschrift voor geneeskunde, 2017, Volume: 161 Topics: Diagnosis, Differential; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography	2017
Treatments for giant cell arteritis: Meta-analysis and assessment of estimates reliability using the fragility index. Seminars in arthritis and rheumatism, 2018, Volume: 48, Issue:1 Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Treatment Outcome	2018
Current and emerging diagnosis tools and therapeutics for giant cell arteritis. Expert review of clinical immunology, 2018, Volume: 14, Issue:7 Topics: Aged; Aged, 80 and over; Animals; Antibodies, Monoclonal, Humanized; Biological Therapy; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Middle Aged; Receptors, Interleukin-6	2018
Treatment of giant cell arteritis. Biochemical pharmacology, 2019, Volume: 165 Topics: Animals; Antibodies, Monoclonal, Humanized; Biological Factors; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Treatment Outcome	2019
[Treatment of giant cell arteritis]. Presse medicale (Paris, France : 1983), 2019, Volume: 48, Issue:9 Topics: Abatacept; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Aspirin; Azathioprine; Drug Administration Schedule; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Leflunomide; Methotrexate; Prednisone; Ustekinumab	2019
Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis. Clinical rheumatology, 2014, Volume: 33, Issue:2 Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dapsone; Female; Giant Cell Arteritis; Humans; Hydroxychloroquine; Immunosuppression Therapy; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Prednisolone; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Treatment Outcome; Vasculitis	2014
Giant cell arteritis. Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 2013, Volume: 36, Issue:6 Topics: Aged; Cyclophosphamide; Diagnostic Imaging; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Japan; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisolone; Prognosis; Pulse Therapy, Drug; Temporal Arteries	2013
Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis. Rheumatic diseases clinics of North America, 2016, Volume: 42, Issue:1 Topics: Disease Management; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Polymyalgia Rheumatica; Shoulder Joint; Temporal Arteries; Ultrasonography	2016
Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review. JAMA, 2016, Jun-14, Volume: 315, Issue:22 Topics: Antibodies, Monoclonal, Humanized; Diagnostic Imaging; Drug Administration Schedule; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Middle Aged; Polymyalgia Rheumatica; Prednisone; Randomized Controlled Trials as Topic	2016
[Management of polymyalgia rheumatica and large vessel vasculitis]. Der Internist, 2016, Volume: 57, Issue:11 Topics: Antirheumatic Agents; Biological Products; Combined Modality Therapy; Evidence-Based Medicine; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Patient Care Management; Polymyalgia Rheumatica; Treatment Outcome	2016
Treatment of giant-cell arteritis, a literature review. Modern rheumatology, 2017, Volume: 27, Issue:5 Topics: Antirheumatic Agents; Azathioprine; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Giant Cell Arteritis; Glucocorticoids; Humans; Medication Therapy Management; Methotrexate; Tumor Necrosis Factor-alpha	2017
Standard and biological treatment in large vessel vasculitis: guidelines and current approaches. Expert review of clinical immunology, 2017, Volume: 13, Issue:4 Topics: Animals; Antibodies, Monoclonal; Azathioprine; Biological Therapy; Clinical Trials as Topic; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Lymphotoxin-alpha; Methotrexate; Practice Guidelines as Topic; Recurrence; Remission Induction; Takayasu Arteritis	2017
[Giant cell arteritis]. La Revue du praticien, 2008, Mar-15, Volume: 58, Issue:5 Topics: Adrenal Cortex Hormones; Aged, 80 and over; Anti-Infective Agents; Biopsy; Blood Sedimentation; C-Reactive Protein; Dapsone; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Prognosis; Radiography; Recurrence; Temporal Arteries; Time Factors; Ultrasonography, Doppler, Duplex	2008
The treatment of giant cell arteritis. Reviews in neurological diseases, 2008,Summer, Volume: 5, Issue:3 Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Brain Ischemia; Drug Administration Schedule; Fibrinolytic Agents; Giant Cell Arteritis; Hospitalization; Humans; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Optic Neuropathy, Ischemic	2008
Giant-cell arteritis. Current opinion in ophthalmology, 2008, Volume: 19, Issue:6 Topics: Aspirin; Blood Sedimentation; C-Reactive Protein; Fibrinogen; Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucocorticoids; Humans; Interleukin-6; Magnetic Resonance Angiography; Methotrexate; Platelet Count; Radiopharmaceuticals; Ultrasonography, Doppler, Color	2008
[Polymyalgia rheumatica]. Deutsche medizinische Wochenschrift (1946), 2009, Volume: 134, Issue:4 Topics: Adrenal Cortex Hormones; Aged; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Methotrexate; Polymyalgia Rheumatica; Tumor Necrosis Factor-alpha	2009
Giant cell arteritis: epidemiology, diagnosis, and management. Current rheumatology reports, 2010, Volume: 12, Issue:6 Topics: Biopsy; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Temporal Arteries; Ultrasonography	2010
[Temporal arteritis: treatment controversies]. Neurologia (Barcelona, Spain), 2010, Volume: 25, Issue:7 Topics: Aspirin; Benzamides; Giant Cell Arteritis; Glucocorticoids; Humans; Imatinib Mesylate; Immunosuppressive Agents; Methotrexate; Middle Aged; Optic Neuropathy, Ischemic; Piperazines; Platelet Aggregation Inhibitors; Protein Kinase Inhibitors; Pyrimidines	2010
Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment. Autoimmunity reviews, 2012, Volume: 11, Issue:6-7 Topics: Aorta; Aortic Aneurysm; Aspirin; Azathioprine; Dendritic Cells; Female; Giant Cell Arteritis; Humans; Macrophages; Magnetic Resonance Angiography; Male; Methotrexate; Positron-Emission Tomography; Sex Factors; T-Lymphocytes; Temporal Arteries; Ultrasonography	2012
Ultrasonographic resolution of the vessel wall oedema with modest clinical improvement in a large-vessel vasculitis patient treated with tocilizumab. Clinical rheumatology, 2012, Volume: 31, Issue:8 Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Aspirin; Biopsy; Drug Resistance; Drug Therapy, Combination; Edema; Giant Cell Arteritis; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Prednisolone; Temporal Arteries; Ultrasonography, Doppler, Duplex	2012
[What have we learned about giant cell arteritis during the last decade?]. La Revue de medecine interne, 2004, Volume: 25, Issue:11 Topics: Adrenal Cortex Hormones; Drug Therapy, Combination; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Methotrexate; Prognosis; Risk Factors	2004
Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis. Arthritis and rheumatism, 2007, Volume: 56, Issue:8 Topics: Administration, Oral; Aged; Chemotherapy, Adjuvant; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Male; MEDLINE; Methotrexate; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome	2007
Vasculitis update, 2007. Bulletin of the NYU hospital for joint diseases, 2007, Volume: 65, Issue:3 Topics: Adrenal Cortex Hormones; Anticoagulants; Antirheumatic Agents; Aspirin; Cyclophosphamide; Giant Cell Arteritis; Granulomatosis with Polyangiitis; Humans; Methotrexate	2007
Five clinical conundrums in the management of giant cell arteritis. Rheumatic diseases clinics of North America, 2007, Volume: 33, Issue:4 Topics: Abortifacient Agents, Nonsteroidal; Aorta; Aortography; Azathioprine; Dilatation, Pathologic; Giant Cell Arteritis; Glucocorticoids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Methotrexate; Prednisone; Pulse Therapy, Drug; Tomography, Spiral Computed; Vision Disorders	2007
Giant cell arteritis. Current opinion in ophthalmology, 2007, Volume: 18, Issue:6 Topics: Adrenal Cortex Hormones; Biopsy; Drug Administration Schedule; Giant Cell Arteritis; Humans; Methotrexate; Methylprednisolone; Platelet Aggregation Inhibitors; Prognosis; Vision Disorders	2007
Improving therapeutic options for patients with giant cell arteritis. Current opinion in rheumatology, 2008, Volume: 20, Issue:1 Topics: Antibodies, Monoclonal; Azathioprine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Randomized Controlled Trials as Topic; Tumor Necrosis Factor-alpha	2008
Treatment of corticosteroid-resistant giant cell arteritis. Rheumatic diseases clinics of North America, 1995, Volume: 21, Issue:1 Topics: Adrenal Cortex Hormones; Drug Resistance; Drug Therapy, Combination; Giant Cell Arteritis; Humans; Methotrexate; Prospective Studies; Time Factors; Treatment Outcome	1995
Steroid-sparing medications in temporal arteritis--report of three cases and review of 174 reported patients. Clinical rheumatology, 1994, Volume: 13, Issue:2 Topics: Aged; Aged, 80 and over; Dapsone; Female; Giant Cell Arteritis; Humans; Methotrexate; Prednisone	1994
Methotrexate use in systemic vasculitis. Rheumatic diseases clinics of North America, 1997, Volume: 23, Issue:4 Topics: Antirheumatic Agents; Clinical Trials as Topic; Female; Giant Cell Arteritis; Granulomatosis with Polyangiitis; Humans; Male; Methotrexate; Prospective Studies; Takayasu Arteritis; Treatment Outcome	1997
[Immunosuppressive agents in Horton's disease. Which drug for which indication?]. Annales de medecine interne, 1998, Volume: 149, Issue:7 Topics: Anti-Inflammatory Agents; Azathioprine; Drug Resistance; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Methotrexate; Patient Selection; Steroids	1998
Low-dose methotrexate as a risk factor for Pneumocystis carinii pneumonia. Military medicine, 1996, Volume: 161, Issue:1 Topics: Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Drug Therapy, Combination; Fatal Outcome; Female; Giant Cell Arteritis; Humans; Immunocompromised Host; Methotrexate; Pneumonia, Pneumocystis; Prednisone; Risk Factors	1996
Giant cell arteritis. Current opinion in rheumatology, 2002, Volume: 14, Issue:1 Topics: Antirheumatic Agents; Giant Cell Arteritis; Humans; Methotrexate; Risk Factors	2002
Polymyalgia rheumatica/temporal arteritis: recent advances. Current rheumatology reports, 2002, Volume: 4, Issue:1 Topics: Adrenal Cortex Hormones; Aged; Azathioprine; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Methotrexate; Middle Aged; Polymyalgia Rheumatica; Randomized Controlled Trials as Topic; Treatment Outcome	2002
Treatment of giant-cell arteritis: where we have been and why we must move on. Cleveland Clinic journal of medicine, 2002, Volume: 69 Suppl 2 Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Aortic Aneurysm; Azathioprine; Drug Therapy, Combination; Giant Cell Arteritis; Humans; Methotrexate; Prednisolone	2002

Trials

7 trial(s) available for methotrexate and Aortic Arteritis, Giant Cell

Article	Year
PolyMyalgia Rheumatica treatment with Methotrexate in Optimal Dose in an Early disease phase (PMR MODE): study protocol for a multicenter double-blind placebo controlled trial. Trials, 2022, Apr-15, Volume: 23, Issue:1 Topics: Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Multicenter Studies as Topic; Polymyalgia Rheumatica; Prednisolone; Randomized Controlled Trials as Topic; Treatment Outcome	2022
A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis and rheumatism, 2002, Volume: 46, Issue:5 Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Blood Sedimentation; Double-Blind Method; Female; Giant Cell Arteritis; Humans; Male; Methotrexate; Middle Aged; Predictive Value of Tests; Recurrence; Treatment Failure	2002
Methotrexate treatment in the management of giant cell arteritis. Scandinavian journal of rheumatology, 1994, Volume: 23, Issue:6 Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Male; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Treatment Outcome	1994
Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis? Annals of the rheumatic diseases, 1996, Volume: 55, Issue:4 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antirheumatic Agents; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Methotrexate; Middle Aged; Polymyalgia Rheumatica; Prednisone; Recurrence	1996
Visual performance in giant cell arteritis (temporal arteritis) after 1 year of therapy. The British journal of ophthalmology, 1999, Volume: 83, Issue:7 Topics: Adrenal Cortex Hormones; Aged; Color Vision Defects; Contrast Sensitivity; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Methotrexate; Methylprednisolone; Prednisolone; Prospective Studies; Sensory Thresholds; Vision Disorders; Visual Acuity	1999
Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial. Annals of internal medicine, 2001, Jan-16, Volume: 134, Issue:2 Topics: Adrenal Cortex Hormones; Aged; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Male; Methotrexate; Placebos; Prednisone; Recurrence; Sensitivity and Specificity; Statistics, Nonparametric	2001
Anti-tumour necrosis factor treatment with infliximab in a case of giant cell arteritis resistant to steroid and immunosuppressive drugs. Rheumatology (Oxford, England), 2002, Volume: 41, Issue:3 Topics: Aged; Antibodies, Monoclonal; Antirheumatic Agents; Azathioprine; Drug Resistance; Drug Therapy, Combination; Female; Giant Cell Arteritis; Health Status; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Pain; Pain Measurement; Prednisone; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha	2002

Other Studies

50 other study(ies) available for methotrexate and Aortic Arteritis, Giant Cell

Article	Year
Clinical practice in giant cell arteritis based on a survey of specialists. Revista clinica espanola, 2022, Volume: 222, Issue:5 Topics: Cross-Sectional Studies; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Surveys and Questionnaires	2022
Polymyalgia Rheumatica and Giant Cell Arteritis: Rapid Evidence Review. American family physician, 2022, Volume: 106, Issue:4 Topics: C-Reactive Protein; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Myalgia; Polymyalgia Rheumatica; Recurrence	2022
Treatment of giant cell arteritis - current approach and new possibilities. Vnitrni lekarstvi, 2022,Fall, Volume: 68, Issue:5 Topics: Biological Factors; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Positron Emission Tomography Computed Tomography	2022
No association between methotrexate and impaired bone mineral density in a cohort of patients with polymyalgia rheumatica, giant cell arteritis, granulomatosis with polyangiitis and other vasculitides-a cross-sectional analysis with dose-response analyses Rheumatology international, 2023, Volume: 43, Issue:5 Topics: Aged; Bone Density; Cohort Studies; Cross-Sectional Studies; Giant Cell Arteritis; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Methotrexate; Middle Aged; Polymyalgia Rheumatica	2023
Efficacy and tolerance of methotrexate in a real-life monocentric cohort of patients with giant cell arteritis. Seminars in arthritis and rheumatism, 2023, Volume: 60 Topics: Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Recurrence; Retrospective Studies	2023
[Treatment of giant cell arteritis]. La Revue du praticien, 2023, Volume: 73, Issue:4 Topics: Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate	2023
[Giant cell arteritis. Experience in 32 patients]. Revista medica de Chile, 2022, Volume: 150, Issue:6 Topics: Aged; Aged, 80 and over; Biopsy; C-Reactive Protein; Female; Giant Cell Arteritis; Humans; Male; Methotrexate; Middle Aged; Retrospective Studies; Steroids; Temporal Arteries	2022
[Large-vessel vasculitis-giant cell and Takayasu arteritis]. Der Internist, 2019, Volume: 60, Issue:10 Topics: Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Female; Giant Cell Arteritis; Giant Cells; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Prednisone; Takayasu Arteritis; Treatment Outcome	2019
[How to manage giant cell arteritis]. Revue medicale suisse, 2020, Jan-15, Volume: 16, Issue:676-7 Topics: Abatacept; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Ultrasonography	2020
Efficacy of methotrexate in polymyalgia rheumatica in routine rheumatology clinical care. Internal medicine journal, 2020, Volume: 50, Issue:9 Topics: Aged; Aged, 80 and over; Blood Sedimentation; Female; Giant Cell Arteritis; Humans; Male; Methotrexate; Polymyalgia Rheumatica; Rheumatology	2020
[Treatment of giant cell arteritis and polymyalgia rheumatica]. Zeitschrift fur Rheumatologie, 2020, Volume: 79, Issue:2 Topics: Drug Administration Schedule; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Polymyalgia Rheumatica	2020
Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA study. Rheumatology (Oxford, England), 2021, 08-02, Volume: 60, Issue:8 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Inflammation; Male; Methotrexate; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisolone; Treatment Outcome	2021
Does methotrexate have no beneficial effect in reducing flares in the treatment of polymyalgia rheumatica patients? Rheumatology international, 2021, Volume: 41, Issue:7 Topics: Drug Administration Schedule; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Polymyalgia Rheumatica	2021
Efficacy of Methotrexate in Real-world Management of Giant Cell Arteritis: A Case-control Study. The Journal of rheumatology, 2019, Volume: 46, Issue:5 Topics: Academic Medical Centers; Aged; Biopsy, Needle; Case-Control Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Methotrexate; Middle Aged; North America; Positron-Emission Tomography; Prednisone; Recurrence; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome	2019
Leflunomide versus methotrexate in treatment of giant cell arteritis: comparison of efficacy, safety, and drug survival. Scandinavian journal of rheumatology, 2019, Volume: 48, Issue:4 Topics: Aged; Antirheumatic Agents; Dose-Response Relationship, Drug; Drug Monitoring; Female; Giant Cell Arteritis; Humans; Leflunomide; Male; Methotrexate; Norway; Patient Acuity; Prednisolone; Remission Induction; Retrospective Studies; Treatment Outcome	2019
Methotrexate in Giant Cell Arteritis Deserves a Second Chance - A High-dose Methotrexate Trial Is Needed. The Journal of rheumatology, 2019, Volume: 46, Issue:5 Topics: Case-Control Studies; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Methotrexate; Prednisone	2019
2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Annals of the rheumatic diseases, 2020, Volume: 79, Issue:1 Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Aortitis; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Takayasu Arteritis	2020
Characteristics and management of giant cell arteritis in France: a study based on national health insurance claims data. Rheumatology (Oxford, England), 2020, 01-01, Volume: 59, Issue:1 Topics: Aged; Antirheumatic Agents; Biopsy; Databases, Factual; Female; France; Giant Cell Arteritis; Humans; Incidence; Male; Methotrexate; National Health Programs; Retrospective Studies; Temporal Arteries; Ultrasonography, Doppler	2020
Giant cell arteritis: a multicenter observational study in Brazil. Clinics (Sao Paulo, Brazil), 2013, Volume: 68, Issue:3 Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Biopsy; Brazil; Female; Giant Cell Arteritis; Humans; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisone; Retrospective Studies; Risk Factors; Sex Factors; Statistics, Nonparametric; Temporal Arteries	2013
Methotrexate in refractory bilateral juvenile temporal arteritis: Report of a case. Modern rheumatology, 2016, Volume: 26, Issue:2 Topics: Adrenal Cortex Hormones; Adult; Antirheumatic Agents; Giant Cell Arteritis; Humans; Male; Methotrexate; Retreatment; Temporal Arteries; Treatment Outcome	2016
Extra-cranial giant cell arteritis: a diagnostic challenge. QJM : monthly journal of the Association of Physicians, 2015, Volume: 108, Issue:10 Topics: Aged; C-Reactive Protein; Female; Giant Cell Arteritis; Humans; Methotrexate; Middle Aged; Platelet Transfusion; Positron-Emission Tomography; Prednisolone; Thrombocytopenia	2015
Tongue necrosis in giant-cell arteritis. QJM : monthly journal of the Association of Physicians, 2015, Volume: 108, Issue:10 Topics: Aged; Biopsy; Diphosphonates; Female; Giant Cell Arteritis; Humans; Methotrexate; Necrosis; Prednisone; Tongue; Vitamin D	2015
Isolated aortitis: a rare cause of febrile illness. BMJ case reports, 2015, Oct-01, Volume: 2015 Topics: Anti-Inflammatory Agents; Antibodies, Antinuclear; Aortitis; Diagnosis, Differential; Female; Fever; Follow-Up Studies; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Prednisolone; Rare Diseases; Takayasu Arteritis; Treatment Outcome	2015
Fully integrated whole-body [18F]-fludeoxyglucose positron emission tomography/magnetic resonance imaging in therapy monitoring of giant cell arteritis. European heart journal, 2016, Feb-07, Volume: 37, Issue:6 Topics: Aged; Anti-Inflammatory Agents; Drug Therapy, Combination; Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucocorticoids; Humans; Magnetic Resonance Angiography; Male; Methotrexate; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals	2016
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone. Journal of the American Geriatrics Society, 2016, Volume: 64, Issue:3 Topics: Adrenal Cortex Hormones; Aged; Cyclophosphamide; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Male; Methotrexate; Retrospective Studies	2016
Coronary and Aortic Involvement as Initial Manifestations of Possible Giant Cell Arteritis in a Patient Without Cardiovascular Comorbidities. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2016, Volume: 22, Issue:7 Topics: Aged; Antirheumatic Agents; Biopsy; Coronary Artery Bypass; Coronary Disease; Diagnosis, Differential; Exercise Test; Female; Giant Cell Arteritis; Humans; Magnetic Resonance Angiography; Methotrexate	2016
Development of autoimmune diseases after vaccination. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2008, Volume: 14, Issue:4 Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Giant Cell Arteritis; Humans; Influenza Vaccines; Male; Methotrexate; Prednisone; Tetanus Toxoid	2008
Giant cell arteritis in Mexican patients. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2012, Volume: 18, Issue:1 Topics: Aged; Aged, 80 and over; Amaurosis Fugax; Antirheumatic Agents; Blindness; Ethnicity; Female; Follow-Up Studies; Giant Cell Arteritis; Headache; Humans; Male; Methotrexate; Mexico; Middle Aged; Polymyalgia Rheumatica; Prednisone; Retrospective Studies	2012
An echocardiographic finding leading to the diagnosis of giant cell arteritis. European heart journal. Cardiovascular Imaging, 2013, Volume: 14, Issue:5 Topics: Aged; Echocardiography, Transesophageal; Fatigue; Follow-Up Studies; Giant Cell Arteritis; Humans; Methotrexate; Methylprednisolone; Positron-Emission Tomography; Risk Assessment; Syncope; Treatment Outcome; Weight Loss	2013
Giant cell arteritis complicated by spinal cord infarction: a therapeutic dilemma. The Journal of rheumatology, 2002, Volume: 29, Issue:7 Topics: Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Giant Cell Arteritis; Humans; Infarction; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Methotrexate; Methylprednisolone; Prednisone; Risk Assessment; Spinal Cord; Spinal Cord Ischemia; Treatment Outcome	2002
[Corticosteroid saving-up in giant cell arteritis?]. Deutsche medizinische Wochenschrift (1946), 2002, Sep-13, Volume: 127, Issue:37 Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Double-Blind Method; Follow-Up Studies; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Placebos; Prednisolone; Randomized Controlled Trials as Topic; Time Factors	2002
Disparate results in studies of methotrexate plus corticosteroids in the treatment of giant cell arteritis: comment on the article by Hoffman et al. Arthritis and rheumatism, 2003, Volume: 48, Issue:4 Topics: Antirheumatic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Giant Cell Arteritis; Humans; Methotrexate; Multicenter Studies as Topic; Placebos; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Reproducibility of Results; Treatment Outcome	2003
Vision loss in giant cell arteritis patients treated with alternate-day corticosteroids: comment on the article by Hoffman et al. Arthritis and rheumatism, 2003, Volume: 48, Issue:4 Topics: Antirheumatic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Giant Cell Arteritis; Humans; Methotrexate; Multicenter Studies as Topic; Placebos; Prednisone; Randomized Controlled Trials as Topic; Reproducibility of Results; Treatment Outcome; Vision, Low	2003
Heeding clues to giant cell arteritis. Prompt response can prevent vision loss. Postgraduate medicine, 2004, Volume: 115, Issue:5 Topics: Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blindness; Female; Giant Cell Arteritis; Headache; Humans; Methotrexate; Polymyalgia Rheumatica	2004
Giant cell arteritis in a patient taking etanercept and methotrexate. The Journal of rheumatology, 2004, Volume: 31, Issue:7 Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Etanercept; Female; Giant Cell Arteritis; Humans; Immunoglobulin G; Methotrexate; Receptors, Tumor Necrosis Factor	2004
First-time manifestation of giant-cell arteritis during methotrexate treatment. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2005, Volume: 11, Issue:4 Topics: Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Psoriatic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Methotrexate; Prednisone	2005
Primary intraocular lymphoma arising during methotrexate treatment of temporal arteritis. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2005, Volume: 40, Issue:5 Topics: Aged, 80 and over; Biomarkers, Tumor; Biopsy; Eye Enucleation; Female; Giant Cell Arteritis; Humans; Immunohistochemistry; Immunosuppressive Agents; Lymphoma, B-Cell; Methotrexate; Retinal Neoplasms	2005
Giant cell arteritis--the methotrexate debate revisited. The Journal of rheumatology, 2006, Volume: 33, Issue:7 Topics: Aged; Aged, 80 and over; Arthritis, Rheumatoid; Blindness; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Male; Methotrexate; Prednisone	2006
Temporal arteritis: report of a case. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2006, Volume: 102, Issue:2 Topics: Aged; Angiography; Anti-Inflammatory Agents; Antirheumatic Agents; Biopsy; Blindness; Female; Giant Cell Arteritis; Humans; Methotrexate; Methylprednisolone	2006
Giant cell arteritis presenting with hemianopic visual field loss. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2007, Volume: 42, Issue:3 Topics: Aged; Biopsy; Blood Sedimentation; Drug Therapy, Combination; Female; Giant Cell Arteritis; Hemianopsia; Humans; Magnetic Resonance Angiography; Methotrexate; Prednisone; Temporal Arteries; Visual Field Tests; Visual Fields	2007
[Giant cell arteritis]. Praxis, 2007, Nov-14, Volume: 96, Issue:46 Topics: Aged; Blood Sedimentation; Diagnosis, Differential; Diagnostic Tests, Routine; Fatigue; Female; Giant Cell Arteritis; Glucocorticoids; Headache; Humans; Methotrexate; Prednisone; Ultrasonography, Doppler, Color; Vision Disorders	2007
Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis. The Journal of rheumatology, 1998, Volume: 25, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Female; Giant Cell Arteritis; Humans; Male; Methotrexate; Middle Aged; Outcome Assessment, Health Care; Polymyalgia Rheumatica; Prednisone	1998
Treating an underdiagnosed cause of headaches. The Johns Hopkins medical letter health after 50, 1998, Volume: 10, Issue:2 Topics: Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate	1998
First-time manifestation of generalized Wegener's granulomatosis despite methotrexate. British journal of rheumatology, 1998, Volume: 37, Issue:3 Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Giant Cell Arteritis; Granulomatosis with Polyangiitis; Humans; Male; Methotrexate; Middle Aged	1998
Giant cell arteritis presenting with proximal weakness and skeletal muscle vasculitis. Muscle & nerve, 1999, Volume: 22, Issue:1 Topics: Aged; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Methotrexate; Muscle Weakness; Muscle, Skeletal; Polymyalgia Rheumatica; Prednisone; Vasculitis, Leukocytoclastic, Cutaneous	1999
[Horton's disease and rhizomelic pseudopolyarthritis. First International Congress on Horton's Disease and rhizomelic pseudopolyarthritis, Prato (Italy), 25-26 May 1999]. La Revue de medecine interne, 1999, Volume: 20, Issue:9 Topics: Adrenal Cortex Hormones; Aged; Antirheumatic Agents; Diagnosis, Differential; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Italy; Methotrexate; Polymyalgia Rheumatica; Randomized Controlled Trials as Topic	1999
Temporal arteritis in Vest Agder County in southern Norway: incidence and clinical findings. The Journal of rheumatology, 2000, Volume: 27, Issue:11 Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Chlorambucil; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Incidence; Male; Methotrexate; Methylprednisolone; Middle Aged; Norway; Polymyalgia Rheumatica; Prednisolone; Vision Disorders	2000
Methotrexate in giant-cell arteritis. Annals of internal medicine, 2001, Dec-04, Volume: 135, Issue:11 Topics: Adrenal Cortex Hormones; Aged; Drug Therapy, Combination; Female; Folic Acid; Folic Acid Antagonists; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Methotrexate	2001
Methotrexate in giant-cell arteritis. Annals of internal medicine, 2001, Dec-04, Volume: 135, Issue:11 Topics: Adrenal Cortex Hormones; Drug Therapy, Combination; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Methotrexate	2001
Methotrexate for corticosteroid-resistant polymyalgia rheumatica and giant cell arteritis. Cleveland Clinic journal of medicine, 1989, Volume: 56, Issue:3 Topics: Aged; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Male; Methotrexate; Middle Aged; Polymyalgia Rheumatica; Prednisone	1989